JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAG
1926
DELISTED
AMAG Pharmaceuticals
AMAG
| $11.6M | ﹤0.01% |
878,381
+332,215
| +61% | +$5.01M |
|
1927
CAE Inc. Common Shares
CAE
$8.74B
| $11.6M | ﹤0.01% |
626,130
-432,450
| -41% | -$7.65M |
|
1928
The Bancorp
TBBK
$2.83B
| $11.6M | ﹤0.01% |
1,170,610
+1,069,247
| +1,055% | +$9.8M |
|
1929
CALL
JD.com
JD
$43.1B
| $11.5M | ﹤0.01% |
278,400
| – | – |
|
|
CZZ
1930
DELISTED
Cosan Limited
CZZ
| $11.5M | ﹤0.01% |
1,187,256
+397,150
| +50% | +$3.59M |
|
1931
Kemper
KMPR
$1.54B
| $11.5M | ﹤0.01% |
167,022
+42,323
| +34% | +$2.73M |
|
1932
TransUnion
TRU
$15.4B
| $11.5M | ﹤0.01% |
209,365
-20,490
| -9% | -$1.09M |
|
1933
Ingevity
NGVT
$2.67B
| $11.5M | ﹤0.01% |
163,168
+41,564
| +34% | +$3M |
|
1934
Universal Insurance Holdings
UVE
$1.19B
| $11.5M | ﹤0.01% |
419,815
+41,838
| +11% | +$1.05M |
|
1935
Timken Company
TKR
$8.91B
| $11.4M | ﹤0.01% |
232,661
-177,336
| -43% | -$8.58M |
|
|
APTI
1936
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $11.4M | ﹤0.01% |
485,941
+78,779
| +19% | +$1.67M |
|
1937
Canadian Solar
CSIQ
$1.08B
| $11.4M | ﹤0.01% |
677,182
+508,067
| +300% | +$8.73M |
|
1938
Future Fuel
FF
$279M
| $11.4M | ﹤0.01% |
810,205
+8,017
| +1% | +$119K |
|
1939
PUT
Skyworks Solutions
SWKS
$10.3B
| $11.4M | ﹤0.01% |
120,200
| – | – |
|
1940
CALL
Eli Lilly
LLY
$1.08T
| $11.4M | ﹤0.01% |
135,100
+87,600
| +184% | +$7.45M |
|
|
CLVS
1941
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.4M | ﹤0.01% |
167,417
+98,271
| +142% | +$6.87M |
|
|
AXE
1942
DELISTED
Anixter International Inc
AXE
| $11.4M | ﹤0.01% |
149,556
+20,832
| +16% | +$1.53M |
|
1943
Mine Safety
MSA
$7.44B
| $11.4M | ﹤0.01% |
146,601
+58,999
| +67% | +$4.71M |
|
1944
Mitsubishi UFJ Financial
MUFG
$249B
| $11.3M | ﹤0.01% |
1,560,580
-424,725
| -21% | -$2.9M |
|
|
RPT
1945
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $11.3M | ﹤0.01% |
769,630
-7,856
| -1% | -$109K |
|
|
MPVD
1946
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $11.3M | ﹤0.01% |
4,119,807
-716,399
| -15% | -$2.05M |
|
|
CSR
1947
Centerspace
CSR
$920M
| $11.3M | ﹤0.01% |
199,020
+168,601
| +554% | +$10M |
|
|
EFII
1948
DELISTED
Electronics for Imaging
EFII
| $11.3M | ﹤0.01% |
381,851
+175,016
| +85% | +$5.86M |
|
1949
Vanguard Health Care ETF
VHT
$19B
| $11.3M | ﹤0.01% |
73,136
+11,124
| +18% | +$1.71M |
|
1950
PUT
Chipotle Mexican Grill
CMG
$40.5B
| $11.3M | ﹤0.01% |
1,950,000
+580,000
| +42% | +$3.46M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.